Deerfield, IL (December 7, 2009) – Astellas Pharma US, Inc. was inducted into the National Minority Organ Tissue Transplant Education Program’s (MOTTEP®) 2009 National Minority Transplant Hall of Fame as the recipient of the Corporate Award. The Hall of Fame honors individuals and organizations who have demonstrated outstanding leadership and dedication in minority organ and tissue transplantation. The Award was presented to Astellas, a leader in the transplant field for more than 20 years, on November 14th during MOTTEP’s 2009 Gala Fundraiser event.

"We are honored to present the Corporate Award to Astellas for its ongoing support of transplant education initiatives and outreach to ethnic minorities and communities-atlarge. The Award also recognizes Astellas’ Transplant Experience program, which provides information and support to ensure that transplant patients lead an optimal quality of life," said Patrice Miles, Executive Director of MOTTEP.

Astellas’ commitment to the transplant community is evident in its work, including:

• Easing the financial burdens of treatment for qualified persons
• Increasing education regarding transplantation and the importance of organ donation through programs such as Transplant Experience
• Providing ongoing patient education and support
• Performing extensive research aimed at new drug development

“Astellas is proud of our position as a leader in the field of transplantation. We know community outreach and education play a pivotal role in securing a successful future for transplantation,” said Maribeth Landwehr, Director of Corporate Communications at Astellas. “We have a commitment to transplantation that goes well beyond obligation. It is our passion and our priority. Astellas will continue to serve as a compelling voice to the community through support and advocacy.”

CNN White House Correspondent, Suzanne Malveaux, presented the Award to Astellas.

About Astellas

Astellas is a recognized leader in transplantation and has been committed to the field of immunology for more than 20 years. Dedicated to supporting the advancement of care for patients, Astellas continues to build upon its legacy and leadership in transplantation by investing in ongoing clinical research and new product development. Astellas Pharma US, Inc., located in Deerfield, Illinois, is a US affiliate of Tokyo-based Astellas Pharma Inc. Astellas is a pharmaceutical company dedicated to improving the health of people around the world through the provision of innovative and reliable pharmaceutical products. The organization is committed to becoming a global category leader in focused areas by combining outstanding R&D and marketing capabilities. In the US, Astellas markets products in the areas of Immunology, Urology, Anti-Infectives, Cardiovascular and Dermatology. For more information about Astellas Pharma US, Inc., please visit our Web site at www.us.astellas.com.